Ads
    Related paper
  1. DAMAGE OF RENAL FUNCTION AND DYNAMICS OF DYSLIPIDEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH INSUFFICIENT GLYCEMIC COMPENSATION UNDER CONDITION OF CORRECTION OF HYPERTENSION WITH ANGIOTENSIN II RECEPTOR ANTAGONISTS
  2. Dynamics of endothelial dysfunction, nephropathic and dyslipidemic disorders in patients with insufficient glycemic compensation of type 2 diabetes mellitus during 1 year of application of angiotensin II receptor antagonists for hypertension correction
  3. Relationship of endothelial dysfunction with degree of renal function damage and lipidemic profile in patients with type 2 diabetes mellitus and hypertension
  4. Endothelial function in patients with diabetes mellitus type 2 with arterial hypertension in good compensation of hyperglycemia
  5. Addition of Metformin to Liraglutide, A GLP-1 Receptor Agonist, Improves Glycemic Control in Patients with Type 2 Diabetes Mellitus
  6. Pathomechanism of Renal Damage in Type 2 Diabetes Mellitus Patients
  7. GLUCOSE METABOLISM CHARACTERISTICS AND THE I/D GENE POLYMORPHISM OF THE ANGIOTENSIN-CONVERTING ENZYME IN THE PATIENTS WITH ARTERIAL HYPERTENSION ACCOMPANYING WITH A TYPE II DIABETES MELLITUS
  8. Role of Glycated Haemoglobin (HbA1c) as a Dual Marker to Predict Glycemic Status and Dyslipidemia in Type II Diabetes Mellitus
  9. A Cross-Sectional Study of Pulmonary Function Tests in Type 2 Diabetes Mellitus and Correlation with Glycemic Index and Duration of Diabetes
  10. The impact of three combinations vildagliptin/metformin, vildagliptin/pioglitazone, and metformin/pioglitazone on glycemic control and atherogenic dyslipidemia in patients with Type 2 diabetes mellitus